• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[已撤回] miR-138通过抑制SOX4抑制胃癌生长。

[Retracted] miR‑138 inhibits gastric cancer growth by suppressing SOX4.

作者信息

Pang Lei, Li Bai, Zheng Baisong, Niu Liang, Ge Liang

机构信息

Department of Anesthesiology, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China.

Department of Colorectal and Anal Surgery, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China.

出版信息

Oncol Rep. 2022 Mar;47(3). doi: 10.3892/or.2022.8258. Epub 2022 Jan 11.

DOI:10.3892/or.2022.8258
PMID:35014683
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8771158/
Abstract

Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that certain of the colony formation assay data shown in Fig. 2C were strikingly similar to data appearing in different form in other articles by different authors. Owing to the fact that the contentious data in the above article had already been published elsewhere, or were already under consideration for publication, prior to its submission to , the Editor has decided that this paper should be retracted from the Journal. After having been in contact with the authors, they agreed with the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused. [the original article was published in 38: 1295‑1302, 20137; DOI: 10.3892/or.2017.5745].

摘要

在本文发表后,一位关注此事的读者提醒编辑注意,图2C中所示的某些集落形成试验数据与不同作者在其他文章中以不同形式出现的数据惊人地相似。由于上述文章中存在争议的数据在提交给本刊之前已在其他地方发表,或已在考虑发表,编辑决定将本文从本刊撤回。在与作者联系后,他们同意撤回该论文的决定。编辑就由此造成的不便向读者表示歉意。[原文发表于《肿瘤学报道》38: 1295 - 1302, 2017;DOI: 10.3892/or.2017.5745]

相似文献

1
[Retracted] miR‑138 inhibits gastric cancer growth by suppressing SOX4.[已撤回] miR-138通过抑制SOX4抑制胃癌生长。
Oncol Rep. 2022 Mar;47(3). doi: 10.3892/or.2022.8258. Epub 2022 Jan 11.
2
[Retracted] Knockdown of CREB1 inhibits tumor growth of human gastric cancer and .[已撤回] CREB1基因敲低抑制人胃癌肿瘤生长及…… (原文此处不完整)
Oncol Rep. 2021 Dec;46(6). doi: 10.3892/or.2021.8202. Epub 2021 Oct 7.
3
[Retracted] miR‑133a inhibits cervical cancer growth by targeting EGFR.[已撤回] miR-133a通过靶向表皮生长因子受体抑制宫颈癌生长。
Oncol Rep. 2021 Jul;46(2). doi: 10.3892/or.2021.8103. Epub 2021 Jun 3.
4
[Retracted] miR‑365 targets ADAM10 and suppresses the cell growth and metastasis of hepatocellular carcinoma.[已撤回] miR-365靶向ADAM10并抑制肝细胞癌的细胞生长和转移。
Oncol Rep. 2022 Nov;48(5). doi: 10.3892/or.2022.8402. Epub 2022 Sep 14.
5
[Retracted] miR‑124 inhibits proliferation and invasion of human retinoblastoma cells by targeting STAT3.[已撤回] miR-124通过靶向STAT3抑制人视网膜母细胞瘤细胞的增殖和侵袭。
Oncol Rep. 2021 Nov;46(5). doi: 10.3892/or.2021.8193. Epub 2021 Sep 24.
6
[Retracted] miR-126 inhibits papillary thyroid carcinoma growth by targeting LRP6.[已撤回] miR-126通过靶向LRP6抑制甲状腺乳头状癌生长。
Oncol Rep. 2021 Jul;46(1). doi: 10.3892/or.2021.8097. Epub 2021 Jun 3.
7
[Retracted] MicroRNA‑154 functions as a tumor suppressor in osteosarcoma by targeting Wnt5a.[已撤回] 微小RNA-154通过靶向Wnt5a在骨肉瘤中发挥肿瘤抑制作用。
Oncol Rep. 2021 Aug;46(2). doi: 10.3892/or.2021.8130. Epub 2021 Jul 19.
8
[Retracted] PAX6, a novel target of miR-335, inhibits cell proliferation and invasion in glioma cells.[已撤回]PAX6是miR-335的一个新靶点,可抑制胶质瘤细胞的增殖和侵袭。
Mol Med Rep. 2021 Sep;24(3). doi: 10.3892/mmr.2021.12299. Epub 2021 Jul 19.
9
[Retracted] miR‑218 suppresses tumor growth and enhances the chemosensitivity of esophageal squamous cell carcinoma to cisplatin.[已撤回] miR-218抑制食管鳞状细胞癌的肿瘤生长并增强其对顺铂的化疗敏感性。
Oncol Rep. 2022 Mar;47(3). doi: 10.3892/or.2022.8265. Epub 2022 Jan 18.
10
[Retracted] MicroRNA‑1297 inhibits metastasis and epithelial‑mesenchymal transition by targeting AEG‑1 in cervical cancer.[已撤回] 微小RNA-1297通过靶向AEG-1抑制宫颈癌的转移和上皮-间质转化
Oncol Rep. 2022 Sep;48(3). doi: 10.3892/or.2022.8372. Epub 2022 Jul 20.